Global Molecular Diagnostics in Cancer Testing Market 2017 Demand, Insights, Key Players, Segmentation and Forecast to 2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 120

Report ID: 105195

Notes:
Sales, means the sales volume of Molecular Diagnostics in Cancer Testing
Revenue, means the sales value of Molecular Diagnostics in Cancer Testing

This report studies sales (consumption) of Molecular Diagnostics in Cancer Testing in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Abbott Molecular Diagnostics
Accugenomics
Agendia
Ambry Genetics
Biodesix
bioMerieux
bioTheranostics (AviaraDx)
Cancer Genetics
Clarient, Inc. (GE Healthcare)
Counsyl
Flatiron Health
Epigenomics
Exact Sciences Corporation
Exiqon
Genomic Health
Genoptix (Novartis)
Genmark Diagnostics
Genomictree
HTG Molecular Diagnostics
Invitae
LabCorp
Myriad Genetics
Nanostring
Neogenomics
NSTG
Nuvera Biosciences
Orion Genomics
Pathway Genomics

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Molecular Diagnostics in Cancer Testing in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Molecular Diagnostics in Cancer Testing in each application, can be divided into
Application 1
Application 2

Table of Contents

Global Molecular Diagnostics in Cancer Testing Sales Market Report 2017
1 Molecular Diagnostics in Cancer Testing Overview
1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing
1.2 Classification of Molecular Diagnostics in Cancer Testing
1.2.1 Type I
1.2.2 Type II
1.3 Application of Molecular Diagnostics in Cancer Testing
1.3.1 Application 1
1.3.2 Application 2
1.4 Molecular Diagnostics in Cancer Testing Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Molecular Diagnostics in Cancer Testing (2012-2022)
1.5.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2022)
1.5.2 Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

2 Global Molecular Diagnostics in Cancer Testing Competition by Manufacturers, Type and Application
2.1 Global Molecular Diagnostics in Cancer Testing Market Competition by Manufacturers
2.1.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Molecular Diagnostics in Cancer Testing Revenue and Share by Manufacturers (2012-2017)
2.2 Global Molecular Diagnostics in Cancer Testing (Volume and Value) by Type
2.2.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Type (2012-2017)
2.2.2 Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)
2.3 Global Molecular Diagnostics in Cancer Testing (Volume and Value) by Regions
2.3.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Regions (2012-2017)
2.3.2 Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Regions (2012-2017)
2.4 Global Molecular Diagnostics in Cancer Testing (Volume) by Application

3 United States Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
3.1 United States Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
3.1.1 United States Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
3.1.2 United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
3.1.3 United States Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
3.2 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
3.3 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
3.4 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

4 China Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
4.1 China Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
4.1.1 China Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
4.1.2 China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
4.1.3 China Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
4.2 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
4.3 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
4.4 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

5 Europe Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
5.1 Europe Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
5.1.1 Europe Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
5.1.2 Europe Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
5.1.3 Europe Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
5.2 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
5.3 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
5.4 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

6 Japan Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
6.1 Japan Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
6.1.1 Japan Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
6.1.2 Japan Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
6.1.3 Japan Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
6.2 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
6.3 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
6.4 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Application
7 Southeast Asia Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
7.1 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
7.1.1 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
7.2 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
7.3 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
7.4 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Application
8 India Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)
8.1 India Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)
8.1.1 India Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)
8.1.2 India Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)
8.1.3 India Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)
8.2 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers
8.3 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Type
8.4 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

9 Global Molecular Diagnostics in Cancer Testing Manufacturers Analysis
9.1 Abbott Molecular Diagnostics
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Accugenomics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Agendia
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Ambry Genetics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Biodesix
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 bioMerieux
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 bioTheranostics (AviaraDx)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Cancer Genetics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Clarient, Inc. (GE Healthcare)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Counsyl
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Flatiron Health
9.12 Epigenomics
9.13 Exact Sciences Corporation
9.14 Exiqon
9.15 Genomic Health
9.16 Genoptix (Novartis)
9.17 Genmark Diagnostics
9.18 Genomictree
9.19 HTG Molecular Diagnostics
9.20 Invitae
9.21 LabCorp
9.22 Myriad Genetics
9.23 Nanostring
9.24 Neogenomics
9.25 NSTG
9.26 Nuvera Biosciences
9.27 Orion Genomics
9.28 Pathway Genomics

10 Molecular Diagnostics in Cancer Testing Maufacturing Cost Analysis
10.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
10.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Molecular Diagnostics in Cancer Testing Market Forecast (2017-2022)
14.1 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Molecular Diagnostics in Cancer Testing Price and Trend Forecast (2017-2022)
14.2 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Molecular Diagnostics in Cancer Testing Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source